Pharmaceutical Analysis & Statistics in Germany, May 2013 (p8)

You might be interested in: therapeutics, drug, cancer, more »

211-260 of about 700 reports

Purchase Reports From Reputable Market Research Publishers

Neupro (Parkinson's Disease) - Forecast and Market Analysis to 2022

Neupro (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Neupro (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : World, Brazil, United Kingdom, Spain, Italy, France, Germany, Japan, Europe, United States
Requip/Requip XL (Parkinson's Disease) - Forecast and Market Analysis to 2022

Requip/Requip XL (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Requip/Requip XL (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and ...

  • Industries : Pathology
  • Countries : France, United Kingdom, World, Spain, Italy, Germany, Japan, Europe, United States
Apokyn (Parkinson's Disease) - Forecast and Market Analysis to 2022

Apokyn (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Apokyn (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : Japan, World, United Kingdom, Spain, Italy, France, Germany, United States, Europe
Azilect (Parkinson's Disease) - Forecast and Market Analysis to 2022

Azilect (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Azilect (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : World, Brazil, United Kingdom, Spain, Italy, France, Germany, Europe, United States
Nouriast (Parkinson's Disease) - Forecast and Market Analysis to 2022

Nouriast (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Nouriast (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : Japan, World, United Kingdom, Spain, Italy, France, Germany, Europe, United States
Safinamide (Parkinson's Disease) - Forecast and Market Analysis to 2022

Safinamide (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Safinamide (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : World, Brazil, United Kingdom, Spain, Italy, France, Germany, Europe, United States
Tozadenant (Parkinson's Disease) - Forecast and Market Analysis to 2022

Tozadenant (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Tozadenant (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : United Kingdom, Spain, Italy, France, Germany, World, Europe, United States
CVT-301 (Parkinson's Disease) - Forecast and Market Analysis to 2022

CVT-301 (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

CVT-301 (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : United Kingdom, Spain, Italy, France, Germany, World, Europe, United States
Rytary/IPX066 (Parkinson's Disease) - Forecast and Market analysis to 2022

Rytary/IPX066 (Parkinson's Disease) - Forecast and Market analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Rytary/IPX066 (Parkinson's Disease) - Forecast and Market analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : United Kingdom, Spain, Italy, France, Germany, World, Europe, United States
PharmaPoint: Parkinson's Disease - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Parkinson's Disease - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Parkinson's Disease - 5EU Drug Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, ...

  • Industries : Pathology
  • Countries : Italy, Spain, France, Germany, United Kingdom, Europe, World
Opicapone (Parkinson's Disease) - Forecast and Market Analysis to 2022

Opicapone (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Opicapone (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : World, United Kingdom, Spain, Italy, France, Germany, Portugal, Europe, United States
Madopar (Parkinson's Disease) - Forecast and Market Analysis to 2022

Madopar (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Madopar (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : World, Brazil, United Kingdom, Spain, Italy, France, Germany, Japan, Europe
Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022

Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : World, Brazil, United Kingdom, Spain, Italy, France, Germany, Japan, Europe, United States
Duodopa (Parkinson's Disease) - Forecast and Market Analysis to 2022

Duodopa (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Duodopa (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : World, United Kingdom, Spain, Italy, France, Germany, Japan, Europe, United States
Stalevo/Comtan (Parkinson's Disease) - Forecast and Market Analysis to 2022

Stalevo/Comtan (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Stalevo/Comtan (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and ...

  • Industries : Pathology
  • Countries : Brazil, Germany, Japan, World, United Kingdom, Europe, United States, Spain, Italy, France, Ireland
Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022

Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available ...

  • Industries : Drug and Medication
  • Countries : Australia, Germany, World, Canada, Spain, Italy, France, Japan, Oceania, New Zealand, Europe, United States, United Kingdom
Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022

Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available ...

  • Industries : Drug and Medication
  • Countries : Australia, World, Canada, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
V503 (Prophylactic Human Papillomavirus Vaccines) - Forecast and Market Analysis to 2022

V503 (Prophylactic Human Papillomavirus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

V503 (Prophylactic Human Papillomavirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. ...

  • Industries : Drug and Medication
  • Countries : Australia, World, Canada, Spain, Italy, France, Germany, United States, United Kingdom, Europe
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - 5EU Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became ...

  • Industries : Drug and Medication
  • Countries : Spain, Italy, France, Germany, United Kingdom, Europe, World
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022

  • $ 10 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became ...

  • Industries : Drug and Medication
  • Countries : World, Australia, Canada, Spain, Italy, United Kingdom, France, Germany, Japan, United States, Europe
EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022

EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • March 2014
  • by Global Data

EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022 Summary Ankylosing spondylitis is a systemic, chronic, and progressive inflammatory arthritis in the family of seronegativespondyloarthritis, ...

  • Industries : Pathology
  • Countries : World, United States, Japan, Europe, Sweden, Spain, Italy, France, Germany, Finland
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017

  • $ 7 995
  • Industry report
  • March 2014
  • by Global Data

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 Summary With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some of the ...

  • Industries : Pathology
  • Countries : United States, World, Europe, Spain, Italy, France, Germany
Germany Contrast Media Injectors Market Outlook to 2020

Germany Contrast Media Injectors Market Outlook to 2020

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

Germany Contrast Media Injectors Market Outlook to 2020 Summary GlobalData's new report, "Germany Contrast Media Injectors Market Outlook to 2020", provides key market data on the Germany Contrast Media ...

  • Industries : Drug Delivery Technology
  • Countries : Germany
Pharmaceutical Product Development, LLC - Strategic SWOT Analysis Review

Pharmaceutical Product Development, LLC - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • March 2014
  • by Global Data

Pharmaceutical Product Development, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains ...

  • Industries : Drug Discovery and Development
  • Countries : Germany
PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2014
  • by Global Data

PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, ...

  • Industries : Pathology
  • Countries : Germany, Spain, Italy, France, United Kingdom, Europe
Seroquel (Schizophrenia) - Forecast and Market Analysis to 2022

Seroquel (Schizophrenia) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • February 2014
  • by Global Data

Seroquel (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory ...

  • Industries : Pathology
  • Countries : Germany, Spain, Italy, France, Japan, World, Europe, United States, United Kingdom
Risperdal (Schizophrenia) - Forecast and Market Analysis to 2022

Risperdal (Schizophrenia) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • February 2014
  • by Global Data

Risperdal (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe
Geodon (Schizophrenia) - Forecast and Market Analysis to 2022

Geodon (Schizophrenia) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • February 2014
  • by Global Data

Geodon (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory ...

  • Industries : Pathology
  • Countries : Spain, Italy, Germany, Japan, World, United States
Aripiprazole Lauroxil (Schizophrenia) - Forecast and Market Analysis to 2022

Aripiprazole Lauroxil (Schizophrenia) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • February 2014
  • by Global Data

Aripiprazole Lauroxil (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe
Cariprazine (Schizophrenia) - Forecast and Market Analysis to 2022

Cariprazine (Schizophrenia) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • February 2014
  • by Global Data

Cariprazine (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe
About 400 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Industry in the US and Germany

  • William A. Gray and Juan F. Granada
  • September 2014
    10 pages
  • Drug And Medica...  

    Drug  

  • United States  

    Germany  

View report >

Tire Industry In Germany

September 2014

Valve Industry In Germany

September 2014

Drug Industry In Germany

September 2014

12 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

Novartis Inc.

Switzerland

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.